CANCER NANOTECHNOLOGY, vol.12, no.1, 2021 (Journal Indexed in SCI)
Background: In this label-free bioassay, an electrochemiluminescence (ECL) immunosensor was developed for the quantification of breast cancer using HER-2 protein as a metastatic biomarker.